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SKIV2L Mutations Cause Syndromic Diarrhea,
or Trichohepatoenteric Syndrome
Alexandre Fabre,1,2 Bernard Charroux,3 Christine Martinez-Vinson,4 Bertrand Roquelaure,2
Egritas Odul,5 Ersin Sayar,6 Hilary Smith,7 Virginie Colomb,8 Nicolas Andre,9 Jean-Pierre Hugot,4
Olivier Goulet,8 Caroline Lacoste,10 Jacques Sarles,2 Julien Royet,3 Nicolas Levy,1,10
and Catherine Badens1,10,*
Syndromic diarrhea (or trichohepatoenteric syndrome) is a rare congenital bowel disorder characterized by intractable diarrhea and
woolly hair, and it has recently been associated with mutations in TTC37. Although databases report TTC37 as being the human ortho-
log of Ski3p, one of the yeast Ski-complex cofactors, this lead was not investigated in initial studies. The Ski complex is a multiprotein
complex required for exosome-mediated RNA surveillance, including the regulation of normal mRNA and the decay of nonfunctional
mRNA. Considering the fact that TTC37 is homologous to Ski3p, we explored a gene encoding another Ski-complex cofactor, SKIV2L, in
six individuals presenting with typical syndromic diarrhea without variation in TTC37. We identified mutations in all six individuals.
Our results show that mutations in genes encoding cofactors of the human Ski complex cause syndromic diarrhea, establishing a link
between defects of the human exosome complex and a Mendelian disease.Syndromic diarrhea (SD) is a rare and severe disease charac-
terized by intractable diarrhea, facial dysmorphism, intra-
uterine growth retardation, immunodeficiency, and hair
abnormalities.1 Trichohepatoenteric (THE [MIM 222470])
syndrome, described initially by Verloes et al. in 19972 as
a different syndrome, has since been grouped with syn-
dromic diarrhea because the main clinical features in
both syndromes are identical3 (for simplicity, we now
refer to both syndromes as a singular disorder, SD/THE
syndrome). After a homozygosity-mapping analysis, we
and others recently identified TTC37 mutations as being
responsible for this syndrome in 21 individuals.4,5 The
precise function of TTC37 (also called Thespin) was not
elucidated even after the description of its involvement
in SD/THE. This protein shares no sequence homology
with other human proteins and shows no known func-
tional domains except several tetratrico-peptide-repeat
(TPR) domains that are structural motifs found in over
300 human proteins.6 In some databases, TTC37 is re-
ported as being the ortholog of yeast SKI3, which encodes
a key component of the Ski complex, a multiprotein
complex required for exosome-mediated RNA surveil-
lance.7 However, this lead was not explored in the initial
studies. In our series, 6 out of 15 individuals did not carry
a mutation in TTC37 but presented with typical character-
istics of SD/THE syndrome. Considering the fact that
TTC37 is homologous to Ski3p, we assumed that other
genes encoding Ski-complex proteins might be responsible
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The Amthis hypothesis with the results of the linkage analysis of
one of the consanguineous families.
Out of the six individuals with typical SD/THE syndrome
and no mutation in TTC37, only one was previously re-
ported.8 All procedures followed for clinical and genetic
analyses in this study were in accordance with the ethical
standards of the institutional and national committees on
human experimentation, and proper informed consent
was obtained from the parents of the affected children. All
individuals presented with severe and intractable diarrhea
that occurred between 1 and 12 weeks after birth, hair ab-
normalities (sparse, fragile, and uncombable hair and tri-
chorrhexis nodosa), and facial dysmorphism characterized
byhypertelorism, a broadflatnasal bridge, and aprominent
forehead (Figure 1). All children received parenteral nutri-
tion, but the amount of time varied between individuals
and ranged from a few weeks to several years. Immunodefi-
ciencywasmostly due to low immunoglobulin levels and to
the absence of an immune response to vaccines. One indi-
vidual out of the three with immunodeficiency died from
a measles infection. These six individuals harbor no muta-
tion in TTC37, but their clinical presentation is undistin-
guishable from those whohaveTTC37mutations (Table 1).
Searching for a candidate gene in this group, we investi-
gated the possible homology (reported in the Ensembl
database) between TTC37 and yeast SKI3. Interspecies
sequence-alignment analysis (with the bioinformatics
prediction software BLAST) revealed that TTC37 shares
significant amino-acid-sequence similarity with yeastseille, France; 2AP-HM, Service de Pe´diatrie Multidisciplinaire, Hoˆpital d’En-
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Figure 1. Clinical Presentation of Individuals
with SD/THE Syndrome and SKIV2L Mutations
(A) Clinical presentation of four individuals with
SD/THE syndrome. One individual has muta-
tions in TTC37 (first picture on the left), and
three others have mutations in SKIV2L (right
panel).
(B) A schematic overview of the predicted SKIV2L
structure with a helicase ATP-binding domain
and a helicase C-terminal domain (UniProt).
The location of the domains is annotated by
amino acid position. The eight amino acid substi-
tutions are indicated by arrows.
(C) Nucleotide sequences are shown for the
controls (upper sequence) and for each SKIV2L
variant (lower sequence). Arrows indicate muta-
tion positions on the reference sequences.Ski3p. Between TTC37 residues 5 and 84, TTC37 and Ski3p
were 35% identical and 58% similar, and between residues
488 and 1223, they were 20% identical and 38% similar,
indicating that TTC37 is the human ortholog of SKI3.
Because Ski3p ispart of amultiprotein complex, thisfinding
prompted us to test whether mutations in other human or-
thologs of the Ski proteins could be associatedwith SD/THE
syndrome. For one consanguineous family, we performed
a linkage analysis in which the TTC37 critical interval
was excluded, and this analysis revealed that there was a
region of homozygosity spanning nucleotides 9,138,488–
40,453,008 and containing 856 genes in chromosomal
region 6p21.2–6p24.3. When looking for functional candi-
date genes in this region, we noticed that SKIV2L (RefSeq
accessionnumberNM_006929.4), a genedescribed asbeing
the human ortholog of the SKI2,9,10 was present in region
6p21.3. Thus, we performed direct sequencing of SKIV2L
in our cohort of six individuals affected by typical SD/THE
syndrome and found the presence of mutations predicted
to be deleterious in all six. The identified mutations
and their mode of inheritance are described in Table 2.
All of the unaffected parents available for analysis were
heterozygous for one of the mutations identified in
their child. We identified eight different variations dis-
tributed throughout the protein (Figure 1). Seven of these
variations correspond to nonsense or frameshift mutations
that introduce apremature terminationcodon, and theyare690 The American Journal of Human Genetics 90, 689–692, April 6, 2012c.848G>A (p.Trp283*), c.1434del (p.Ser479-
Alafs*3), c.1635_1636insA (p.Gly546Argfs*
35), c.226C>T (p.Arg756*), c.2442G>A
(p.Trp814*), c.2572del (p.Val858*), and
c.2662_2663del (p.Arg888Glyfs*12). The
mutation types suggest that the disease
mechanism is loss of function.We identified
one missense mutation, c.1022T>G
(p.Val341Gly), that is located in the helicase
ATP-binding domain (Figure 1) and con-
cerns a highly conserved residue. PolyPhen
predicted that this specificmutation is prob-
ably damaging (the prediction score was 2.8[mutations predicted to be pathological have an index
above 0.5]).
It isnowclear that themajorityof genomic information is
transcribed into RNAmolecules; this process generates very
abundant and complex pools of RNAs that the cells have to
control.While performing numerous RNA-processing reac-
tions, the cell must, at the same time, eradicate surplus and
aberrantmaterial.11 This task is, at least partially, performed
by the RNA exosome multiprotein complex that contains
both 30-to-50 exonuclease and 30-to-50 endonuclease activity
and acts in both the nucleus and the cytoplasm.12 Initially
discovered in yeast but also present in higher eukaryotes,
including humans, this exosome complex is involved in
the decay pathways of normal mRNA but is also required
to maintain the fidelity of gene expression through RNA
surveillance processes, such as nonsense-mediated decay,
nonstop decay, and no-go decay.13–16 Genetic screens in
yeast have identified three proteins (Ski2p, Ski3p, and
Ski8p) that form the Ski (Superkiller) complex and act as
specific cofactors required for all the functions of the cyto-
plasmic exosome but not the nuclear exosome.17 The puta-
tive DExH-box RNA helicase activity of Ski2 suggests that it
is the only Ski protein with a catalytic function, whereas
Ski3p and Ski8p contain repeated domains thought to be
needed for protein-protein interactions.18 In humans, the
cytoplasmic exosome is involved in various mRNA decay
pathways and is required for normal cell growth.19
Table 1. Clinical Data of Individuals Affected by SD/THE
Syndrome
Individuals
with Mutations
in TTC37 (n ¼ 18)
Individuals
with Mutations
in SKIV2L (n ¼ 6)
Premature birth (<37 weeks) 9/17 2/5
Intrauterine growth restriction 14/17 4/6
Birth weight
(median and mean) in kg
1.84 (0.78–3.58);
1.868
1.6 (1.01–2.00);
1.47
Intractable diarrhea 18/18 6/6
Onset of diarrhea
(median and mean) in weeks
3.5 (1–32); 7.75 2.5 (1–12); 3.8
Villous atrophy 16/18 3/5
Colitis 5/6 3/3
Facial dysmorphism 18/18 6/6
Hair abnormalities 18/18 6/6
Trichorrhexis nodosa 17/18 5/5
Immune deficiency 17/18 3/6
Liver disease 9/16 3/6
Siderosis 3/14 1/3
Cirrhosis 7/15 2/3
Skin abnormalities 7/16 3/4
Platelet abnormalities 7/17 0/2
Cardiac abnormalities 4/16 2/4
Outcome (deceased/alive) 4/14 2/4Here, we show that in six families, molecular defects in
the cytoplasmic-exosome cofactor SKIV2L cause SD/THE
syndrome, a severe autosomal-recessive condition mainly
characterized by intractable diarrhea and woolly hair. This
study establishes a formal link between a constitutional
congenital disease and defects of human cytoplasmic-exo-
some cofactors. Although SD/THE syndrome is genetically
heterogeneous and is associated with at least two different
genes, it is extremely homogenous at the clinical level
(Table 1), suggesting that a defect in Ski-complex function
or structure is a key mechanism responsible for the main
clinical features. Consequently,WDR61, the human ortho-
log of the third cofactor SKI8, will be a relevant candidateTable 2. Mutations in SKIV2La, Geographical Origins, and Consanguin
Individual Mutation 1 Mutation 2
1 c.1635_1636insA (p.Gly546Argfs*35) c.1635_1636insA
2 c.2266C>T (p.Arg756*) c.2442G>A (p.T
3 c.848G>A (p.Trp283*) c.1022T>G (p.V
4 c.2572del (p.Val858*) c.2572del (p.Val
5 c.2662_2663del (p.Arg888Glyfs*12) c.2662_2663del
6 c.1434del (p.Ser479Alafs*3) c.1434del (p.Ser
aRefSeq accession numbers NP_008860.4 and NM_006929.4.
The Amgene to be tested in persons that are affected by THE
syndrome and that have no mutation in TTC37 or SKIV2L
sequences (a situation not encountered in our series).
In human pathology, the exosome complex has previ-
ously been involved in autoimmune diseases, in which
components of the nuclear or cytoplasmic exosome are
the target of autoimmune response, or in cancer.20 Here,
we point out that exosome dysfunctionmust be considered
a cause of Mendelian disorders. The association between
mutations in exosome-cofactor-encoding genes and
human diseases provides a valuablemodel for investigating
the role of this structure in human pathology but also in
normal cellular function. The mechanism by which
mRNA-surveillance defects lead to various clinical symp-
toms, such as severe diarrhea, hair abnormalities, or immu-
nodeficiency, will need to be investigated in further studies.
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